• Latest Posts

Five companies racing to bring their NASH treatments toward the finish line

Podcast 1 Dec 2023

Ipsen drug gives hope for liver disease patients

Five latest advancements in NASH research

First drug discovered through 3D bioprinted tissue disease model


Orphalan announces U.S. launch of drug to treat Wilson disease

Ablaze Pharmaceuticals to develop first-in-class therapy for liver cancer in China

Gut microbiota to be harnessed as a tool to diagnose diseases

Antibody candidate for treating serious liver disease

Alcohol-related liver disease: mechanism could lead to new therapies

Vir Biotech presents new data for functional cure of chronic Hep B virus